+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Abuse Deterrent"

Opioids Market - Global Forecast 2026-2032 - Product Thumbnail Image

Opioids Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
Fentanyl Market - Global Forecast 2026-2032 - Product Thumbnail Image

Fentanyl Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Tapentadol Market - Global Forecast 2026-2032 - Product Thumbnail Image

Tapentadol Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
From
From
From
Hydromorphone API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Hydromorphone API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Opioid Narcotics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Opioid Narcotics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
Opioid Analgesics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Opioid Analgesics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Oxycodone Hydrochloride Market - Global Strategic Business Report - Product Thumbnail Image

Oxycodone Hydrochloride Market - Global Strategic Business Report

  • Report
  • February 2026
  • 361 Pages
  • Global
From
Opioid Use Disorder - Global Strategic Business Report - Product Thumbnail Image

Opioid Use Disorder - Global Strategic Business Report

  • Report
  • February 2026
  • 177 Pages
  • Global
From
Morphine Drugs - Global Strategic Business Report - Product Thumbnail Image

Morphine Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 469 Pages
  • Global
From
Gabapentin - Global Strategic Business Report - Product Thumbnail Image

Gabapentin - Global Strategic Business Report

  • Report
  • February 2026
  • 477 Pages
  • Global
From
Opioids - Global Strategic Business Report - Product Thumbnail Image

Opioids - Global Strategic Business Report

  • Report
  • February 2026
  • 189 Pages
  • Global
From
Morphine Drugs Market Report 2025 - Product Thumbnail Image

Morphine Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Oxycodone Drugs Market Report 2025 - Product Thumbnail Image

Oxycodone Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Tramadol Drug Global Market Report 2025 - Product Thumbnail Image

Tramadol Drug Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Oxycodone Hydrochloride Global Market Report 2025 - Product Thumbnail Image

Oxycodone Hydrochloride Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Acetaminophen-Opioid Combination Global Market Report 2025 - Product Thumbnail Image

Acetaminophen-Opioid Combination Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Opioid Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Loading Indicator

The Abuse Deterrent market within the context of Analgesics is a growing sector of the pharmaceutical industry. Abuse Deterrent formulations are designed to reduce the potential for misuse and abuse of prescription medications. These formulations are designed to make the drug less attractive to abusers, such as by making it harder to crush, snort, or inject. Abuse Deterrent formulations are also designed to reduce the potential for accidental overdose. The Abuse Deterrent market is driven by the need to reduce the misuse and abuse of prescription medications, as well as the need to reduce the potential for accidental overdose. This market is expected to continue to grow as more pharmaceutical companies develop Abuse Deterrent formulations. Some companies in the Abuse Deterrent market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Johnson & Johnson. Show Less Read more